Css LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Css LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.2 - $14.24 $25,242 - $85,582	-6,010 Reduced 37.41%	10,056 $67,000
Q3 2022 Nov 14, 2022	SELL	$9.85 - $16.83 $348,030 - $594,654	-35,333 Reduced 68.74%	16,066 $233,000
Q2 2022 Aug 15, 2022	SELL	$8.16 - $15.1 $63,648 - $117,780	-7,800 Reduced 13.18%	51,399 $506,000
Q1 2022 May 16, 2022	BUY	$11.2 - $16.97 $271,040 - $410,674	24,200 Added 69.14%	59,199 $873,000
Q3 2021 Nov 15, 2021	BUY	$17.11 - $24.49 $248,095 - $355,105	14,500 Added 70.74%	34,999 $611,000
Q2 2021 Aug 16, 2021	SELL	$23.12 - $29.91 $450,007 - $582,168	-19,464 Reduced 48.71%	20,499 $491,000
Q1 2021 May 17, 2021	BUY	$14.69 - $42.57 $482,331 - $1.4 Million	32,834 Added 460.57%	39,963 $1.03 Million
Q4 2020 Feb 16, 2021	BUY	$12.88 - $19.47 $91,821 - $138,801	7,129 New	7,129 $135,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $250M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.